<DOC>
	<DOCNO>NCT01220622</DOCNO>
	<brief_summary>The trial design test hypothesis early treatment nimodipine positive effect cognition impairment acute ischemic stroke .</brief_summary>
	<brief_title>Efficacy Safety Study Nimodipine Prevent Mild Cognitive Impairment After Acute Ischemic Strokes</brief_title>
	<detailed_description>656 patient diagnose acute cerebral ischemia disease ( onset≤7d ) base ICD-10 CT/MRI criterion , cognitive impairment meeting inclusion criterion none exclusion criterion , include randomized nimodipine treatment group control group.Evaluations cognitive function take baseline , 1 month , 3 month , 6 month .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Nimodipine</mesh_term>
	<criteria>1 . Subjects 30 80 year . 2 . ICD10 CT/MRI criterion acute cerebral infarction . 3 . Stroke within 7 day onset . 4.based year education correction.MMSE＞17 ( illiteracy ) , MMSE＞20 ( primary school ) , MMSE＞24 ( others ) 5 . MoCA≤26 baseline . 6.Hachinski ischemic score ≥7 baseline . 7.Expected good compliance study . 8.Informed consent sign . 1.Diagnosis schizophrenia , major anxiety syndrome , major depression . 2.Alzheimer disease , Parkinson disease , Huntington disease , frontotemporal dementia . 3.Dementia cause ( e.g. , central nervous system trauma , tumor , infection , metabolic disorder , normal pressure hydrocephalus , lack folic acid vitamin B12 , thyroid hormone deficiency ) . 4.Contraindications dihydropyridine derivative . 5.Aphasia disease affect cognitive evaluation . 6.Serious arrhythmia , bradycardia ( &lt; 50 bpm ) tachycardia ( &gt; 120 bpm ) ; myocardial infarction within past 6 month ; blood pressure &lt; 90/60mmHg ; severe renal hepatic insufficiency ; severe anemia , Hb &lt; 100g/L ; severe gastrointestinal disorder ; tumor . 7.History epilepsy , use antiepileptic drug . 8.CT/MRI show neurodegenerative change lesion except cerebral ischemia .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Mild cognitive impairment</keyword>
	<keyword>Nimodipine</keyword>
</DOC>